Skip to content

Energy · Depth · Target tissue

Device-Based Treatments

Laser, light, radiofrequency and ultrasound are energy classes, not ready-made treatment protocols. The exact system, route, target tissue, labelled use and clinical aim must be identified before suitability is discussed.

Different devices sold under similar names are not assumed equivalent. No online page can choose settings, depth, applicator, treatment line or session number.

Four levels before method selection

A reasoned sequence begins with the clinical question.

Online review can organise the question. Final suitability follows from in-person examination, the exact product or device and an individual risk–benefit assessment.

01

Define the clinical finding

Diagnosis and a limited clinical aim precede device choice.

02

Identify the system

The exact device, energy source, applicator and consumables are verified.

03

Map tissue and risk

Invasiveness, target depth, skin type and vulnerable anatomy shape suitability.

04

Plan evidence and exit

Device-specific evidence, alternatives, follow-up and stopping criteria are agreed.

Needle, laser and ultrasound routes remain distinct

Invasive path, optical columns and focused sound require different safety maps.

RF microneedling, fractional lasers and focused ultrasound differ in energy, route, target tissue and labelled context.

01Device-specific route

RF Microneedling

RF microneedling explained by needle system, radiofrequency delivery, device label, target tissue, evidence, risks, alternatives and stopping criteria.

Decision boundaryMicroneedling and RF indications are device-, body-area- and region-specific; clearance of one system does not authorise another use.
Open RF Microneedling
02Device-specific route

Fractional Laser Treatment

Fractional laser treatment with ablative and non-ablative systems separated by wavelength, chromophore, tissue effect, recovery and safety.

Decision boundaryLabelled indications and body areas are product- and jurisdiction-specific; wavelength alone does not establish authorisation.
Open Fractional Laser Treatment
03Device-specific route

Microfocused Ultrasound / HIFU

Microfocused ultrasound and HIFU separated by device, imaging, transducer, focal depth, labelled use, tissue target, evidence and neurological risks.

Decision boundaryMicrofocused ultrasound, systems with visualisation and broad HIFU marketing terms are not automatically equivalent; labelled uses differ by product and region.
Open Microfocused Ultrasound / HIFU

Light targets require diagnosis and chromophore logic

IPL, pigment laser and vascular laser are not interchangeable.

Broad-spectrum filtered light and wavelength-specific lasers retain separate target, skin-type and eye-safety decisions.

04Device-specific route

IPL Treatment

IPL explained as filtered broad-spectrum non-laser light with device, filter, pulse, chromophore, skin type, evidence and ocular safety boundaries.

Decision boundaryAuthorised indications, filters, body sites and operators vary by exact IPL product and region.
Open IPL Treatment
05Device-specific route

Pigment Laser

Pigment laser treatment with diagnosis and malignancy exclusion before wavelength, pigment depth, skin type, evidence, risks and alternatives.

Decision boundaryA device label does not authorise treatment of every brown lesion; regional indication and lesion type must match.
Open Pigment Laser
06Device-specific route

Vascular Laser

Vascular laser assessment by vessel diagnosis, diameter, depth, anatomy, wavelength, cooling, evidence, risks and alternatives.

Decision boundaryClearance or marking applies to a named product, indication and region; a wavelength alone is not a treatment authorisation.
Open Vascular Laser

Current path, fibre path and low-level light stay separate

Radiofrequency, interstitial laser and PBM/LED have different invasiveness and aims.

A shared marketing promise cannot merge unlike energy delivery, tissue exposure or evidence.

07Device-specific route

Radiofrequency Skin Tightening

Radiofrequency skin tightening separated by electrode arrangement, energy path, invasiveness, tissue target, thermal control, evidence and implant risks.

Decision boundaryThe exact system's labelled indication, tissue, anatomical site and regional status must be verified; RF is not one device class clinically.
Open Radiofrequency Skin Tightening
08Device-specific route

Interstitial Fibre Laser

Interstitial fibre laser separated from surface laser and surgery by fibre path, invasiveness, target tissue, licence, evidence, complications and alternatives.

Decision boundaryThe exact device, fibre, intended tissue, access route and regional authorisation must be verified; marketing names do not establish a licensed indication.
Open Interstitial Fibre Laser
09Existing EN-I5 route

Photobiomodulation / LED

Existing canonical page for wavelength-, irradiance-, dose- and device-specific light assessment.

Decision boundaryLinked once; no duplicate page or canonical is created.
Open Photobiomodulation / LED

Four binding principles

Premium care means clearer selection, boundaries and follow-up.

Advertising language and package logic are replaced by product traceability, anatomy, proportionate alternatives and documented review.

01

Diagnosis before energy

A device name never substitutes for examination.

02

Identity before equivalence

Similar marketing names do not make systems interchangeable.

03

Anatomy before settings

Energy path and vulnerable structures define the safety boundary.

04

Review before repetition

Expected reactions, complications and the endpoint are assessed before another procedure.

International patient pathway

Travel, examination and follow-up form one medical process.

The in-person appointment remains the decision point. Product records, early safety, return travel and local medical access are considered before treatment.

  1. 01

    Organise the question

    History and photographs prepare discussion without selecting a device.

  2. 02

    Examine in person

    Diagnosis, anatomy, exact system, label and alternatives are reviewed.

  3. 03

    Keep traceability

    Device, consumable, region and observations remain recorded.

  4. 04

    Arrange escalation

    Stop criteria and local medical access are agreed before departure.

Dr İsmail Aslan wearing a white medical coat
Dr İsmail AslanMedical DoctorClinical Focus: Hair Transplantation · Aesthetic Medicine

Medical decision before machine selection

The device follows the tissue question.

Doctor Aslan keeps system identity, energy path, anatomy, label, evidence and alternatives in the same decision.

01

Separate technologies

Laser, IPL, RF, ultrasound and LED retain different mechanisms.

02

Verify the system

Manufacturer, model, applicator and intended use remain traceable.

03

Use a test area when medically appropriate

A test area, documented parameters and the observed tissue response can limit avoidable overtreatment.

04

Accept no treatment

Withholding a device remains a valid medical decision.

Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information; no personal device selection, settings or outcome guarantee

Short and clear

Questions commonly asked before a decision.

These answers provide general orientation and do not replace personal diagnosis or treatment planning.

01How is a device selected within Device-Based Treatments?

Selection begins with the diagnosis, personal finding and aim. Only then are the exact device, applicator, protocol, risks and alternatives compared.

02Is an online pre-assessment enough for a treatment decision?

No. It can organise records and questions. Final diagnosis, suitability and planning are determined only after an in-person medical examination in Istanbul.

03Are an outcome or a fixed number of sessions promised?

No. A responsible plan states the baseline, task, review point and criteria for continuing, changing or stopping.

04How is follow-up planned from abroad?

The contact route, expected reactions, warning signs, local medical help and documented follow-up checks are agreed before treatment.

Define the finding · identify the device · compare alternatives

Which device route, if any, belongs in the assessment?

Online Pre-Assessment can organise the question. It cannot diagnose, select a device, set energy parameters or confirm suitability.